Sour black mulberry (Morus nigra L.) causes cell death by decreasing mutant p53 expression in HT-29 human colon cancer cells

被引:23
作者
Erden, Yavuz [1 ]
机构
[1] Bartin Univ, Dept Mol Biol & Genet, Fac Sci, TR-74000 Bartin, Turkey
关键词
Sour black mulberry; Morus nigra; HT-29; cells; Colon cancer; Mutant p53; ALBA L; WILD-TYPE; ANTIOXIDANT; PHYTOCHEMICALS; RESISTANCE; SURVIVAL; THERAPY; DAMAGE;
D O I
10.1016/j.fbio.2021.101113
中图分类号
TS2 [食品工业];
学科分类号
0832 ;
摘要
Cancer is an important health problem and obtaining new information about the treatment of this disease is an important gain. Morus nigra L. (black mulberry) is an important medical plant in Asia and Europe and has an important place in food and folk medicine. The present study aimed to determine the anti-cancer effect of sour black mulberry on human colon cancer cell (HT-29). In the current investigation, total phenols and flavonoids contents and antioxidant activity of plant extract were quantified by Folin-Ciocalteu's, AlCl3 and DPPH methods, respectively. The anti-cancer effects of the M. nigra on HT-29 cells were determined by cytotoxic, genotoxic, and molecular analyses. The phenolic content of M. nigra was determined as 192.67 +/- 5.15 mg/g and the total flavonoid level to 125.86 +/- 1.72 mg/g and exhibited a strong DPPH inhibition effect. Plant extract significantly increased DNA damage and reduced cell viability. It was determined that M. nigra application caused an increase in Bax/Bcl-2 levels and a decrease in p53 and procaspase-3 levels. These results indicate that M. nigra mediates cell death in a caspase-3 independent pathway by decreasing mutant p53 expression in HT-29 cells.
引用
收藏
页数:7
相关论文
共 43 条
[1]   Wild-type p53 induced sensitization of mutant p53 TNF-resistant cells:: Role of caspase-8 and mitochondria [J].
Ameyar-Zazoua, M ;
Larochette, N ;
Dorothée, G ;
Daugas, E ;
Haddada, H ;
Gouloumet, V ;
Métivier, D ;
Stancou, R ;
Mami-Chouaib, F ;
Kroemer, G ;
Chouaib, S .
CANCER GENE THERAPY, 2002, 9 (03) :219-227
[2]   Phytochemistry, pharmacology, and clinical trials of Morus alba [J].
Chan, Eric Wei-Chiang ;
Lye, Phui-Yan ;
Wong, Siu-Kuin .
CHINESE JOURNAL OF NATURAL MEDICINES, 2016, 14 (01) :17-30
[3]   Wild-type and mutant p53 mediate cisplatin resistance through interaction and inhibition of active caspase-9 [J].
Chee, Jacqueline L. Y. ;
Saidin, Suzan ;
Lane, David P. ;
Leong, Sai Mun ;
Noll, Jacqueline E. ;
Neilsen, Paul M. ;
Phua, Yi Ting ;
Gabra, Hani ;
Lim, Tit Meng .
CELL CYCLE, 2013, 12 (02) :278-288
[4]  
Chen LM, 2011, ATL AMB PERVAS INTEL, V4, P1, DOI 10.1097/COC.0b013e3181fe41ed
[5]   Tumour heterogeneity and resistance to cancer therapies [J].
Dagogo-Jack, Ibiayi ;
Shaw, Alice T. .
NATURE REVIEWS CLINICAL ONCOLOGY, 2018, 15 (02) :81-94
[6]   Plant Phenolics: Extraction, Analysis and Their Antioxidant and Anticancer Properties [J].
Dai, Jin ;
Mumper, Russell J. .
MOLECULES, 2010, 15 (10) :7313-7352
[7]   Multiple Chronic Conditions and Use of Complementary and Alternative Medicine Among US Adults: Results From the 2012 National Health Interview Survey [J].
Falci, Laura ;
Shi, Zaixing ;
Greenlee, Heather .
PREVENTING CHRONIC DISEASE, 2016, 13
[8]   Real time monitoring and quantification of reactive oxygen species in breast cancer cell line MCF-7 by 2′,7′-dichlorofluorescin diacetate (DCFDA) assay [J].
Figueroa, Daniela ;
Asaduzzaman, Mohammad ;
Young, Fiona .
JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS, 2018, 94 :26-33
[9]   Reliance on medicinal plant therapy among cancer patients in Jamaica [J].
Foster, Kimberley ;
Younger, Novie ;
Aiken, William ;
Brady-West, Doreen ;
Delgoda, Rupika .
CANCER CAUSES & CONTROL, 2017, 28 (11) :1349-1356
[10]   Wild-type and mutant p53 proteins interact with mitochondrial caspase-3 [J].
Frank, Amanda K. ;
Pietsch, E. Christine ;
Dumont, Patrick ;
Tao, Joy ;
Murphy, Maureen E. .
CANCER BIOLOGY & THERAPY, 2011, 11 (08) :740-745